当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析 - 现金流量表

威尔药业

(603351)

  

流通市值:36.96亿  总市值:36.96亿
流通股本:1.35亿   总股本:1.35亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金851,253,624.16541,036,690.03249,896,152.111,135,771,763.99
  收到的税费返还9,394,046.717,411,708.542,724,054.5312,819,014.05
  收到其他与经营活动有关的现金16,493,616.578,508,936.092,877,052.116,543,019.56
  经营活动现金流入小计877,141,287.44556,957,334.66255,497,258.751,155,133,797.6
  购买商品、接受劳务支付的现金482,949,599.65312,887,938.14152,541,659.62605,965,686.12
  支付给职工以及为职工支付的现金117,195,796.8886,818,533.0658,403,376.27141,871,979.5
  支付的各项税费59,658,467.6940,493,102.2516,053,632.379,477,421.96
  支付其他与经营活动有关的现金36,790,880.422,704,744.0611,300,605.2189,573,774.43
  经营活动现金流出小计696,594,744.62462,904,317.51238,299,273.4916,888,862.01
  经营活动产生的现金流量净额180,546,542.8294,053,017.1517,197,985.35238,244,935.59
二、投资活动产生的现金流量:
  收回投资收到的现金3,973,509.921,192,052.97-13,875,137.27
  取得投资收益收到的现金---24,989.15
  处置固定资产、无形资产和其他长期资产收回的现金净额1,300--223,484.62
  收到的其他与投资活动有关的现金429,500429,500100,000-
  投资活动现金流入小计4,404,309.921,621,552.97100,00014,123,611.04
  购建固定资产、无形资产和其他长期资产支付的现金64,390,787.4737,179,880.2614,125,404.0852,179,557.37
  投资支付的现金5,000,0005,000,0005,000,00036,000,000
  取得子公司及其他营业单位支付的现金31,532,021.5816,628,035.58--
  支付其他与投资活动有关的现金400,000400,000--
  投资活动现金流出小计101,322,809.0559,207,915.8419,125,404.0888,179,557.37
  投资活动产生的现金流量净额-96,918,499.13-57,586,362.87-19,025,404.08-74,055,946.33
三、筹资活动产生的现金流量:
  取得借款收到的现金231,000,000200,000,000200,000,000551,000,000
  筹资活动现金流入小计231,000,000200,000,000200,000,000551,000,000
  偿还债务支付的现金470,500,000359,000,000181,000,000461,320,400
  分配股利、利润或偿付利息支付的现金89,143,243.7887,357,234.813,479,085.9864,888,778.72
  支付其他与筹资活动有关的现金7,481,346.054,757,063.562,228,909.2511,487,056.65
  筹资活动现金流出小计567,124,589.83451,114,298.37186,707,995.23537,696,235.37
  筹资活动产生的现金流量净额-336,124,589.83-251,114,298.3713,292,004.7713,303,764.63
四、汇率变动对现金及现金等价物的影响-1,972,614.31-2,034,687.19-1,868,455.15-828,047.87
五、现金及现金等价物净增加额-254,469,160.45-216,682,331.289,596,130.89176,664,706.02
  加:期初现金及现金等价物余额423,865,188.4423,865,188.4423,865,188.4247,200,482.38
  期末现金及现金等价物余额169,396,027.95207,182,857.12433,461,319.29423,865,188.4
补充资料:
  净利润-75,524,877.16-148,987,071.3
  资产减值准备-1,939,822.41-6,031,196.28
  固定资产和投资性房地产折旧-59,047,986.89-118,503,969.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,047,986.89-118,503,969.25
  无形资产摊销-2,546,776.48-4,858,741.16
  长期待摊费用摊销-125,867.38-251,734.7
  处置固定资产、无形资产和其他长期资产的损失----16,250.03
  固定资产报废损失-66,362.56-422,240.97
  公允价值变动损失-1,823,673.41--3,413,109.64
  财务费用-8,439,791.96-11,509,279.77
  投资损失-36,570.48--24,989.15
  递延所得税-1,174,936.94-3,590,369.63
  其中:递延所得税资产减少--2,079,714.34-2,010,121.38
    递延所得税负债增加-3,254,651.28-1,580,248.25
  存货的减少--7,821,142.91--10,120,648.95
  经营性应收项目的减少--58,091,705.47--414,811,189.1
  经营性应付项目的增加-4,006,684.27-365,188,350.8
  其他----2,429,607.96
  不涉及现金收支的投资和筹资活动金额其他项目---52,397,400.62
  现金的期末余额-207,182,857.12-423,865,188.4
  减:现金的期初余额-423,865,188.4-247,200,482.38
  现金及现金等价物的净增加额--216,682,331.28-176,664,706.02
公告日期2026-10-292026-08-222026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑